PortfoliosLab logoPortfoliosLab logo
ETLI.DE vs. WELP.DE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ETLI.DE vs. WELP.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in L&G Pharma Breakthrough UCITS ETF (ETLI.DE) and HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELP.DE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ETLI.DE achieves a 9.42% return, which is significantly lower than WELP.DE's 25.35% return.


ETLI.DE

1D
1.19%
1M
9.79%
YTD
9.42%
6M
8.58%
1Y
39.82%
3Y*
8.41%
5Y*
2.73%
10Y*

WELP.DE

1D
0.00%
1M
-7.19%
YTD
25.35%
6M
26.72%
1Y
34.31%
3Y*
12.49%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ETLI.DE vs. WELP.DE - Yearly Performance Comparison


2026 (YTD)2025202420232022
ETLI.DE
L&G Pharma Breakthrough UCITS ETF
9.42%22.18%0.42%-12.66%1.96%
WELP.DE
HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF
25.35%-1.54%7.90%0.25%5.34%

Correlation

The correlation between ETLI.DE and WELP.DE is -0.14, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Sep 20, 2022

0.12

The correlation between ETLI.DE and WELP.DE shifts across timeframes, from -0.14 (1 year) to 0.12 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ETLI.DE vs. WELP.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ETLI.DE
ETLI.DE Risk / Return Rank: 7676
Overall Rank
ETLI.DE Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
ETLI.DE Sortino Ratio Rank: 7474
Sortino Ratio Rank
ETLI.DE Omega Ratio Rank: 6565
Omega Ratio Rank
ETLI.DE Calmar Ratio Rank: 8787
Calmar Ratio Rank
ETLI.DE Martin Ratio Rank: 7878
Martin Ratio Rank

WELP.DE
WELP.DE Risk / Return Rank: 5757
Overall Rank
WELP.DE Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
WELP.DE Sortino Ratio Rank: 5252
Sortino Ratio Rank
WELP.DE Omega Ratio Rank: 5555
Omega Ratio Rank
WELP.DE Calmar Ratio Rank: 6464
Calmar Ratio Rank
WELP.DE Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ETLI.DE vs. WELP.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for L&G Pharma Breakthrough UCITS ETF (ETLI.DE) and HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELP.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ETLI.DEWELP.DEDifference
Sharpe ratioReturn per unit of total volatility

+0.34

Sortino ratioReturn per unit of downside risk

+0.65

Omega ratioGain probability vs. loss probability

1.34

1.31

+0.04

Calmar ratioReturn relative to maximum drawdown

4.39

2.80

+1.59

Martin ratioReturn relative to average drawdown

13.14

8.57

+4.57

ETLI.DE vs. WELP.DE - Sharpe Ratio Comparison

The current ETLI.DE Sharpe Ratio is 2.09, which is comparable to the WELP.DE Sharpe Ratio of 1.75. The chart below compares the historical Sharpe Ratios of ETLI.DE and WELP.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ETLI.DE vs. WELP.DE - Drawdown Comparison

The maximum ETLI.DE drawdown since its inception was -30.84%, which is greater than WELP.DE's maximum drawdown of -23.55%. Use the drawdown chart below to compare losses from any high point for ETLI.DE and WELP.DE.


Loading charts...

Drawdown Indicators


ETLI.DEWELP.DEDifference

Max Drawdown

Largest peak-to-trough decline

-30.84%

-23.55%

-7.29%

Max Drawdown (1Y)

Largest decline over 1 year

-9.04%

-12.22%

+3.18%

Max Drawdown (3Y)

Largest decline over 3 years

-23.14%

-23.55%

+0.41%

Max Drawdown (5Y)

Largest decline over 5 years

-30.84%

Current Drawdown

Current decline from peak

0.00%

-11.07%

+11.07%

Average Drawdown

Average peak-to-trough decline

-10.04%

-7.79%

-2.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.02%

3.99%

-0.97%

Volatility

ETLI.DE vs. WELP.DE - Volatility Comparison

L&G Pharma Breakthrough UCITS ETF (ETLI.DE) and HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELP.DE) have volatilities of 6.27% and 6.59%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ETLI.DEWELP.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.27%

6.59%

-0.32%

Volatility (6M)

Calculated over the trailing 6-month period

14.29%

16.90%

-2.61%

Volatility (1Y)

Calculated over the trailing 1-year period

19.01%

19.54%

-0.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.31%

20.07%

-2.76%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.71%

20.07%

-1.36%

ETLI.DE vs. WELP.DE - Expense Ratio Comparison

ETLI.DE has a 0.49% expense ratio, which is lower than WELP.DE's 0.59% expense ratio.


Dividends

ETLI.DE vs. WELP.DE - Dividend Comparison

ETLI.DE has not paid dividends to shareholders, while WELP.DE's dividend yield for the trailing twelve months is around 3.05%.


PositionTTM202520242023
ETLI.DE
L&G Pharma Breakthrough UCITS ETF
0.00%0.00%0.00%0.00%
WELP.DE
HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF
3.05%3.78%3.64%0.79%

Frequently Asked Questions


ETLI.DE and WELP.DE have a correlation of -0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, ETLI.DE is cheaper at 0.49% per year. The better choice depends on whether you care most about return, fees, risk, or income.

ETLI.DE is cheaper with a 0.49% expense ratio, compared with 0.59% for WELP.DE.

ETLI.DE tracks Solactive Pharma Breakthrough Value, while WELP.DE tracks MSCI World/Energy NR USD. They also come from different issuers: Legal & General and Amundi. Their fees differ too: 0.49% for ETLI.DE and 0.59% for WELP.DE.

Portfolio Optimizer

Find the right allocation for ETLI.DE and WELP.DE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer